Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01945580 · ClinicalTrials.gov registry record · NA
Xenform Postmarket Surveillance Study
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 374
- Enrollment target
NCT01945580 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 374 participants.
The verdict
NCT01945580, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 374 participants
- Enrollment target
Study Summary
To compare transvaginal repair with a biologic graft to traditional native tissue repair in women surgically treated for anterior and/or apical pelvic organ prolapse.
Interventions
- PROCEDURE Prolapse Repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 374 participants |
| Start Date | 2014-02-10 |
| Est. Completion | 2020-02-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01945580
The ClinicalTrials.gov registry entry for NCT01945580 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 374 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prolapse Repair is the first listed.
NCT01945580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01945580 about?
NCT01945580 is a clinical study titled "Xenform Postmarket Surveillance Study". To compare transvaginal repair with a biologic graft to traditional native tissue repair in women surgically treated for anterior and/or apical pelvic organ prolapse.
What is the current status of trial NCT01945580?
This trial is currently completed. It is a NA study. The enrollment target is 374 participants. The study started on 2014-02-10. Estimated completion is 2020-02-12.
What interventions are being tested in trial NCT01945580?
The interventions under investigation include: Prolapse Repair (PROCEDURE).
Who is sponsoring clinical trial NCT01945580?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.